GlassScriptPhysician profile
Supriya Rao
NPI 1215250162
$1,623.68
in general payments reported to CMS, 2019-2025
25 companies · $99.18 in 2025
The $99.18 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $98.45 · 2021: $297 · 2022: $138 · 2023: $423 · 2024: $385 · 2025: $99.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.51 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $267.40 | 2022-2025 | Veozah |
| Abbvie INC. | $233.04 | 2020-2023 | |
| Mayne Pharma Commercial LLC | $170.00 | 2022-2024 | |
| Therapeuticsmd, INC. | $103.35 | 2019-2020 | |
| Boston Scientific Corporation | $103.00 | 2019-2024 | Varithena Administration Pack |
| Biogen, INC. | $81.72 | 2024-2025 | Zurzuvae |
| Organon LLC | $76.81 | 2024-2025 | Nexplanon |
| Becton, Dickinson and Company | $76.21 | 2022-2024 | Arista Ah Flexitip |
| Caldera Medical, INC | $74.90 | 2021 | |
| Sumitomo Pharma America, INC. | $59.38 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $48.27 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $46.62 | 2020-2024 | Gardasil 9, Gardasil |
| Hologic Sales and Service, LLC | $46.25 | 2023 | Aptima |
| Amag Pharmaceuticals, INC. | $32.66 | 2019-2020 | |
| Exeltis, USA INC. | $30.27 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $25.38 | 2023 | |
| Roche Diagnostics Corporation | $24.27 | 2019 | |
| Shield Therapeutics INC | $21.41 | 2024 | |
| Myovant Sciences INC. | $18.93 | 2022 | |
| Davol INC. | $17.40 | 2024 | |
| Agile Therapeutics, INC. | $14.20 | 2022 | |
| Lsi Solutions INC | $13.64 | 2023 | Fornisee |
| Novo Nordisk INC | $13.62 | 2019 | |
| Allergan, INC. | $13.39 | 2019 | |
| Vivus LLC | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Supriya Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.